TRPM1s

TRPM1s is a splice variant of the Transient Receptor Potential Melastatin 1 (TRPM1) channel, a member of the TRP channel superfamily of non‑selective cation channels. The canonical TRPM1 protein is encoded by the TRPM1 gene located on human chromosome 15q24.1. TRPM1s arises from alternative splicing that deletes a large portion of the protein’s C‑terminal domain, resulting in a shorter polypeptide of approximately 600 amino acids. Despite its truncated structure, TRPM1s can still form homomeric channels and associate with full‑length TRPM1 subunits, forming heteromeric complexes that modulate channel gating and ion permeability.

TRPM1s is predominantly expressed in retinal ON‑bipolar cells, where it contributes to the light‑responsive depolarization that occurs in response to depolarization of photoreceptors. Recent studies indicate that TRPM1s may fine‑tune the ON pathway by modifying the channel’s conductance and thus the magnitude of the postsynaptic response. In addition, TRPM1s expression has been detected in some peripheral tissues, including the pineal gland and certain muscles, suggesting auxiliary roles in calcium signaling and cellular excitability.

Clinically, loss‑of‑function mutations in TRPM1 are associated with congenital stationary night blindness (CSNB) and with a subset of melanoma cases where the gene is down‑regulated or undergoes promoter hypermethylation. While the functional impact of TRPM1s mutations has not been fully delineated, mutations affecting splice sites that abolish TRPM1s production can disrupt normal retinal signaling, potentially contributing to visual pathologies.

Research on TRPM1s is ongoing. Investigations into its biophysical properties, interaction with regulatory proteins, and involvement in disease could provide insights into retinal physiology and the development of therapeutic strategies for visual disorders.